Initially, we assessed the expression of Oct4, a marker for pluripotent stem cells [44], αSMA, a marker commonly expressed by smooth muscle cells but also mesenchymal stromal cells [59], and ALDH1A1 which is expressed in both normal and cancer stem cell populations [45]. The gene discussed is ALDH1A1; the disease is cancer.